4 min read
Atherosclerosis Treatment Algorithms for Heart Disease Evaluation
Quantification of coronary artery disease (CAD) burden and atherosclerotic plaque type has been shown to be the strongest determinant of future risk...
4 min read
Quantification of coronary artery disease (CAD) burden and atherosclerotic plaque type has been shown to be the strongest determinant of future risk...
3 min read
Care quality is a pillar of the Quadruple Aim for a reason. Stakeholders across the healthcare ecosystem benefit when patients have access to the...
3 min read
Cleerly’s Medical Affairs team had the opportunity to present at the American Heart Association’s (AHA) 2022 Scientific Sessions this past week in...
3 min read
Myocardial perfusion, also known as a "stress test", is today's go-to-method for detecting coronary artery disease - despite limited performance.
3 min read
There's a little-known fact in cardiology: Most of the care that's provided doesn't prevent heart attacks.
1 min read
Cleerly CEO James Min, M.D., is a guest on the latest episode of the AWS Health Innovation Podcast hosted by Joe Shonkwiler, M.D.
3 min read
Findings from Cleerly's groundbreaking echo the recent American College of Cardiology guidelines on the use of CCTA for non-invasive heart disease...
2 min read
As Cleerly makes its way into the clinical workflow of health systems and providers across the US, we are learning valuable information about how to...